Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Market shares* of insulin pens/cartridges and vials/syringes by country (2002 to 2012)

From: Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand

  2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
BRAZIL ***            
Pens/cartridges** 26.17 29.46 34.71 32.75 36.05 38.15 40.37 43.59 46.38 36.71 29.91
Analogue 1.82 3.89 8.56 14.43 21.38 26.53 30.11 33.43 36.47 27.73 19.81
Human 24.34 25.57 26.15 18.31 14.67 11.62 10.26 10.16 9.91 8.98 10.10
Vials/syringes** 73.83 70.54 65.29 67.25 63.95 61.85 59.63 56.41 53.62 63.29 70.09
Analogue 2.11 2.78 4.14 5.68 6.55 7.17 7.20 7.60 8.12 5.32 4.22
Animal 24.16 19.73 15.40 14.39 5.88 0.55 0.00 0.00 0.00 0.00 0.00
Human 47.56 48.03 45.75 47.19 51.52 54.12 52.43 48.81 45.50 57.97 65.87
CHINA            
Pens/cartridges** 43.61 48.41 55.81 62.33 67.69 72.71 77.21 80.14 82.86 84.69 85.66
Analogue 0.00 0.33 0.58 1.31 3.58 8.02 14.20 20.35 25.52 30.23 33.92
Animal 0.00 0.00 0.00 0.00 0.31 0.53 0.67 0.62 0.77 0.92 0.52
Human 43.61 48.07 55.23 61.03 63.80 64.16 62.34 59.17 56.57 53.54 51.21
Vials/syringes ** 56.39 51.59 44.19 37.67 32.31 27.29 22.79 19.86 17.14 15.31 14.34
Analogue 0.00 0.00 0.00 0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.03
Animal 39.18 36.64 30.33 24.25 21.61 18.08 15.35 14.34 12.72 11.47 10.46
Human 17.21 14.96 13.86 13.42 10.70 9.19 7.44 5.51 4.42 3.84 3.85
THAILAND HOSPITAL            
Pens/cartridges** 9.25 11.36 15.92 23.46 31.08 37.30 40.83 47.48 48.26 48.95 51.02
Analogue 0.15 0.23 0.41 1.15 1.98 3.66 4.78 5.84 6.24 6.12 6.66
Human 9.10 11.13 15.52 22.31 29.10 33.63 36.05 41.65 42.02 42.83 44.36
Vials/syringes** 90.75 88.64 84.08 76.54 68.92 62.70 59.17 52.52 51.74 51.05 48.98
Analogue 0.00 0.24 0.81 0.79 0.51 0.44 0.36 0.25 0.23 0.17 0.12
Human 90.75 88.40 83.27 75.75 68.42 62.27 58.81 52.27 51.51 50.88 48.86
THAILAND RETAIL            
Pens/cartridges ** 15.91 17.12 21.40 25.78 30.18 38.99 44.37 45.44 54.21 59.35 62.02
Analogue 0.23 0.50 0.62 1.32 2.75 6.86 10.36 15.01 21.33 24.21 27.43
Human 15.68 16.61 20.78 24.46 27.43 32.13 34.01 30.43 32.88 35.14 34.59
Vials/syringes** 84.09 82.88 78.60 74.22 69.82 61.01 55.63 54.56 45.79 40.65 37.98
Analogue 0.00 0.00 0.00 0.00 0.10 0.86 1.23 1.26 1.22 0.72 0.72
Human 84.09 82.88 78.60 74.22 69.72 60.15 54.40 53.29 44.57 39.93 37.26
  1. *Market share is the percentage of the total market volume based on volume sold in international units per 1000 population.
  2. **Pens/cartridges includes: CARTRIDGES, P-F PENS, CARTRIDGES RET and P-F PENS RET. Vials/syringes includes: VIAL, VIAL SC and VIAL SC RET.
  3. ***Exubera was excluded from the analysis because it is an inhaled insulin thus it does not fit the classification applied; it was used only in Brazil, in the years 2007 and 2008, accounting for only 0.15 and 0.03% of the market share.